Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 2Glioma 2Glioblastoma 2Brain Neoplasms 2Wilms Tumor 1Sarcoma 1Rhabdomyosarcoma 1Retroperitoneal Neoplasms 1Pleural Effusion, Malignant 1Peritoneal Neoplasms 1Peritoneal Cavity Cancer 1Oligodendroglioma 1Neuroblastoma 1Neoplasms 1Myeloproliferative Disorder, Chronic, with Eosinophilia 1Mesothelioma, Malignant 1High Grade Serous Ovarian 1Gliosarcoma 1Gastrointestinal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Carcinoma 1Astrocytoma 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Adenocarcinoma 1

Interventions

Oxaliplatin 1Leucovorin 1Fluorouracil 1Cytoreduction Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Peritoneal Cavity Cancer × Cytoreduction Surgical Procedures × Clear all
NCT00625092 2017-11-29

Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
17 enrolled

Peritoneal Cavity Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡